What this means
This trial plans to give people a daily multivitamin or a placebo pill and check blood cell function. It has not reported results, so it cannot yet show whether vitamins help aging.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 40–60 · 150 sedentary men and women aged 40 to 60
- Where
- 1 site, including California
The science
- Registered title
- Multivitamin and Mineral Supplementation and Healthy Aging
- Trial ID
- NCT07642869 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Healthy Aging, Multivitamin and Mineral Supplementation
- What is tested
- MVM Core Blend, MVM Gold Blend, Placebo
- Sponsor
- University of California, San Diego
- Ages
- 40 Years to 60 Years
- Dates
- First posted Jun 11, 2026 · updated Jun 15, 2026
Registry summary
The goal of this study is to determine the impact of MVM supplementation on clinical and biochemical markers associated with healthy aging, with a particular focus on mitochondrial function and metabolism. Specifically, changes in mitochondrial respiration using isolated blood cells will be measured. This method has been used to compare with various other age-related markers of health such as physical function, gait speed, and resting metabolic rate. It is hypothesize that MVM supplementation will impact the function of blood cells. MVM supplementation impacts other markers of health, including serum nutrient levels, metabolomic profiles, physical function, and skeletal muscle composition and quality will be explored. These comprehensive assessments will provide insights into the potential benefits of MVM supplementation for healthy aging and address critical gaps in our understanding of its immediate effects. Further, this study will aid in the understanding of how multivitamin supplements can support heathy aging in mid-life adults, a key time to start including wellness programs in people's lives.
The study cohort will consist of 150 sedentary men and women aged 40-60-years of age. A double-blind, three-arm, placebo-controlled randomized clinical trial will be conducted. Participants will receive a daily oral tablet containing one of two possible formulations of vitamins and minerals or a placebo. The three groups will be MVM "GOLD" blend formula, the US Restage MVM "US CORE", and the placebo group.
Sites (1)
- University of California, San Diego, La Jolla, California, United States
